Aps Pharmatechnologies Private Limited - Company Profile

It is a paper private limited company based in Panvel, Maharashtra, India, established in 2024.
2024 Panvel, Maharashtra, India Active
Last Updated:
Access Report
About Aps Pharmatechnologies Private Limited

Aps Pharmatechnologies Private Limited, a active private limited company, was established on 29 July 2024 in Panvel, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002MH2024PTC429700. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Arati Kumar Singh (Director), Preeti Vaibhav Nemane (Director), Sujata Vilas Wani (Director). It is based at Flat-910, Plot-68, Sec-05, Ulwe Manas, Raigarh, Panvel, Maharashtra, 410206.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002MH2024PTC429700

  • Registration Number

    429700

  • Incorporation Date

    29 July 2024

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 7 Months
Company report

Aps Pharmatechnologies Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aps Pharmatechnologies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aps Pharmatechnologies Private Limited?
Current Directors
Name Designation Appointment Date Status
Arati Kumar Singh Director 29 Jul 2024 Current
Preeti Vaibhav Nemane Director 29 Jul 2024 Current
Sujata Vilas Wani Director 29 Jul 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aps Pharmatechnologies.

Enhance accessibility to Aps Pharmatechnologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Aps Pharmatechnologies revenue growth over time
Aps Pharmatechnologies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aps Pharmatechnologies?

Unlock access to Aps Pharmatechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aps Pharmatechnologies?

Unlock and access historical data on people associated with Aps Pharmatechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aps Pharmatechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aps Pharmatechnologies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aps Pharmatechnologies
Recent Activity within the Organization
  • Director Appointment

    Progress on Arati Kumar Singh was appointed as a Director was appointed as a Director on 29 Jul 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Director Appointment

    The activity Preeti Vaibhav Nemane was appointed as a Director was appointed as a Director on 29 Jul 2024 & has been associated with this company since 1 year 7 months . was completed.

  • Director Appointment

    Progress on Sujata Vilas Wani was appointed as a Director was appointed as a Director on 29 Jul 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Company Incorporation

    Aps Pharmatechnologies Private Limited was registered on 29 Jul 2024 with Roc Mumbai Ii & aged 1 year 7 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aps Pharmatechnologies Private Limited?

The CIN of Aps Pharmatechnologies Private Limited is U21002MH2024PTC429700.

Where is Aps Pharmatechnologies Private Limited headquartered?

Aps Pharmatechnologies Private Limited is headquartered at Flat-910, Plot-68, Sec-05, Ulwe Manas, Raigarh, Panvel, Maharashtra, 410206.

When was Aps Pharmatechnologies Private Limited incorporated?

Aps Pharmatechnologies Private Limited was incorporated on 29 July 2024.

Who are the current directors of Aps Pharmatechnologies Private Limited?

The current directors of Aps Pharmatechnologies Private Limited are

What is the primary industry of Aps Pharmatechnologies Private Limited?

The primary industry of Aps Pharmatechnologies Private Limited is Paper.

Is Aps Pharmatechnologies Private Limited a listed company?

Aps Pharmatechnologies Private Limited is unlisted.

What is the capital structure of Aps Pharmatechnologies Private Limited?

The authorized capital of Aps Pharmatechnologies Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available